-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Mineralys Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2022 to 2024.
- Mineralys Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$19.1M, a 49.8% decline year-over-year.
- Mineralys Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$166M, a 105% decline from 2023.
- Mineralys Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$81.2M, a 178% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)